Medical Therapy for Functional Mitral Regurgitation

Area of Science:

• Cardiology
• Cardiac Surgery
• Heart Failure Research

Background:

• Functional mitral regurgitation (FMR) presents as ventricular or atrial types, often coexisting.
• Ventricular FMR stems from left ventricular remodeling (heart failure with reduced ejection fraction) or papillary muscle issues.
• Atrial FMR arises from atrial/annular dilation (atrial fibrillation/flutter) or elevated atrial pressures (heart failure with preserved ejection fraction).

Purpose of the Study:

• To review medical therapeutic options for managing functional mitral regurgitation.
• To highlight a targeted medical approach for distinct FMR categories.
• To identify clinical and echocardiographic predictors for low medical therapy yield and optimal interventional timing.

Main Methods:

• Literature review of current FMR management strategies.
• Analysis of guideline-directed medical therapy (GDMT) efficacy.
• Synthesis of clinical and echocardiographic data for treatment guidance.

Main Results:

• Guideline-directed medical therapy is the primary treatment for FMR.
• Specific medical approaches are beneficial for distinct ventricular and atrial FMR subtypes.
• Echocardiographic and clinical parameters can predict response to medical therapy.

Conclusions:

• Tailored medical therapy is crucial for managing functional mitral regurgitation.
• Understanding FMR mechanisms guides treatment selection.
• Identifying patients unlikely to benefit from medical therapy allows for timely consideration of interventions.